Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Effects of Health Promotion Since Childhood

All clinical practice guidelines indicate healthy lifestyle recommendations and, as cardiologists, we have slowly but surely implemented such practice.

promoción de los hábitos saludables desde la niñez

However, patients come to us once they have had health problems. What would happen if people had these recommendations at an earlier stage in their life? Would that prevent them from ever becoming patients?

There was some logic to that idea, but it had to be tested in the long term to see if the lifestyle change provoked was sustained over time and if new interventions were necessary.

That is why this study tested the long-term impact of health promotion on preschool children in an urban low-income area of Colombia (phase 1). Additionally, researchers assessed the effects of a new community intervention (phase 2).


Read also: ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.


In phase 1, researchers conducted an analysis of knowledge, attitudes, and habits toward a healthy lifestyle, and ideal cardiovascular health scores in 1216 children. Among them, 596 had previously received health promotion recommendations at 3 to 5 years old. The remaining 620 subjects had not taken part in any prior intervention.

In phase 2, all children were randomized 1:1 to undergo either an additional 4-month educational intervention (the SI! Program) or no other intervention (the control group).

The primary endpoint were the changes from baseline in healthy lifestyle and ideal cardiovascular health scores.


Read also: Maintaining Physical Activity After an Acute Myocardial Infarction Reduces Mortality.


In phase 1, about 85% of children did not have a healthy lifestyle. Those who had previously taken part in a preschool intervention at 3 to 5 years old showed a practically negligible residual effect compared with those who took part in an intervention at 9 to 13 years old.

In phase 2, there was no difference between the 4-month intervention group and the control group.

All of that notwithstanding, there was a dose-response effect. The maximal benefit was observed in children who attended >75% of the scheduled intervention program.


Read also: The Crucial Significance of Lifestyle Changes.


The difference in healthy lifestyle changes between the high- and low-adherence groups was 3.72 points (p < 0.001).

Conclusion

While there were no significant differences between the intervention and control groups, high adherence rates to health promotion interventions might improve future cardiovascular health.

New interventions may be required at multiple stages to induce sustained health promotion effects.

Original Title: Sustainability of and Adherence to Preschool Health Promotion Among Children 9 to 13 Years Old.

Reference: Rodrigo Fernández-Jiménez et al. J Am Coll Cardiol 2020;75:1565–78.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...